Claude F. Meares
#159,336
Most Influential Person Now
Claude F. Meares's AcademicInfluence.com Rankings
Download Badge
Chemistry
Why Is Claude F. Meares Influential?
(Suggest an Edit or Addition)Claude F. Meares's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. (1984) (345)
- Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. (1988) (208)
- Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. (1985) (194)
- Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. (1993) (182)
- Metal chelates as probes of biological systems (1984) (167)
- Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA. (1974) (164)
- The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex. (1988) (162)
- Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. (1990) (153)
- Indium-111-labeled autologous platelets for location of vascular thrombi in humans. (1978) (141)
- Copper-64-labeled antibodies for PET imaging. (1992) (141)
- RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. (1995) (131)
- Transfer of oxygen from an artificial protease to peptide carbon during proteolysis. (1991) (130)
- Specific cleavage of a protein by an attached iron chelate (1990) (126)
- Diffusion-enhanced fluorescence energy transfer. (1982) (123)
- Comparative serum stability of radiochelates for antibody radiopharmaceuticals. (1987) (116)
- Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. (1997) (116)
- Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. (1988) (110)
- A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging. (2008) (107)
- Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. (1995) (103)
- Antibodies with infinite affinity (2001) (99)
- Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. (1990) (98)
- Element-coded affinity tags for peptides and proteins. (2004) (96)
- Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. (2011) (92)
- Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. (1992) (88)
- RNA contacts subunits IIo and IIc in HeLa RNA polymerase II transcription complexes. (1986) (87)
- A new route to "bifunctional" chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid. (1979) (86)
- Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. (1993) (81)
- Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis. (1998) (79)
- Zinc is associated with the beta subunit of DNA-dependent RNA polymerase of Bacillus subtilis. (1977) (77)
- Advances in pretargeting biotechnology. (2001) (77)
- Iron chelate mediated proteolysis: Protein structure dependence (1991) (76)
- Mapping the σ70 subunit contact sites on Escherichia coli RNA polymerase with a σ70-conjugated chemical protease (1998) (76)
- 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma. (1999) (75)
- Positioning of two alpha subunit carboxy-terminal domains of RNA polymerase at promoters by two transcription factors. (1997) (75)
- Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy. (1994) (74)
- High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody (2005) (73)
- Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. (1997) (71)
- 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. (1999) (71)
- Effect of Slow Rotational Diffusion on Angular Correlations (1972) (70)
- Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study. (1998) (68)
- Macrocyclic chelates of radiometals for diagnosis and therapy. (1990) (66)
- Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins (2001) (65)
- A comparative study of copper‐67 radiolabeling and kinetic stabilities of antibody‐macrocycle chelate conjugates (1994) (63)
- Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer (1994) (62)
- The two alpha subunits of Escherichia coli RNA polymerase are asymmetrically arranged and contact different halves of the DNA upstream element. (1997) (61)
- Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. (1995) (60)
- Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates. (1998) (59)
- Covalent attachment of metal chelates to proteins:the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indium. (1976) (59)
- Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10 (1996) (58)
- Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. (1999) (57)
- Topography of transcription: path of the leading end of nascent RNA through the Escherichia coli transcription complex. (1983) (56)
- Bledta II: Synthesis of a new tumor-visualizing derivative of CO(III)-bleomycin (1981) (56)
- Comparative toxicity studies of yttrium‐90 mx‐dtpa and 2‐it‐bad conjugated monoclonal antibody (bre‐3) (1994) (56)
- BLEDTA: tumor localization by a bleomycin analogue containing a metal-chelating group. (1979) (55)
- Cobalt-bleomycins and deoxyribonucleic acid: sequence-dependent interactions, action spectrum for nicking, and indifference to oxygen. (1984) (54)
- Light-induced nicking of deoxyribonucleic acid by cobalt(III) bleomycins. (1982) (54)
- Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. (1990) (53)
- Positioning of σS, the stationary phase σ factor, in Escherichia coli RNA polymerase–promoter open complexes (1999) (52)
- Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymerase. (1999) (51)
- Synthesis of the protein cutting reagent iron (S)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetate and conjugation to cysteine side chains. (1997) (51)
- Mapping the promoter DNA sites proximal to conserved regions of sigma 70 in an Escherichia coli RNA polymerase-lacUV5 open promoter complex. (1998) (51)
- Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji). (1997) (50)
- Decomposition rates of radiopharmaceutical indium chelates in serum (1979) (49)
- Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. (1992) (49)
- Phosphorylation-Induced Signal Propagation in the Response Regulator NtrC (2000) (49)
- Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice. (1995) (48)
- Binding of the sigma 70 protein to the core subunits of Escherichia coli RNA polymerase, studied by iron-EDTA protein footprinting. (1996) (48)
- Stable bifunctional chelates of metals used in radiotherapy. (1990) (48)
- Chelating agents for the binding of metal ions to antibodies. (1986) (46)
- Antibody responses to macrocycles in lymphoma. (1996) (46)
- Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals. (1986) (46)
- Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method. (1994) (46)
- In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. (1991) (45)
- Metabolizable 111in chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice (1986) (45)
- Serum stability of 67Cu chelates: comparison with 111In and 57Co. (1986) (45)
- Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system. (1998) (44)
- Method to site-specifically identify and quantitate carbonyl end products of protein oxidation using oxidation-dependent element coded affinity tags (O-ECAT) and nanoliquid chromatography Fourier transform mass spectrometry. (2006) (44)
- Protein-protein interactions mapped by artificial proteases: where sigma factors bind to RNA polymerase. (2000) (43)
- Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. (2010) (43)
- Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts. (1998) (42)
- Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library. (1998) (42)
- Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging (2008) (41)
- Synthesis of mono- and dinucleotide photoaffinity probes of ribonucleic acid polymerase. (1981) (41)
- Characterization of transferrin metal-binding sites by diffusion-enhanced energy transfer. (1980) (40)
- Pretargeting: general principles; October 10-12, 1996. (1997) (40)
- The attachment of metal-chelating groups to protein: tagging of albumin by diazonium coupling and use of the products as radiopharmaceuticals. (1978) (39)
- Linking radiometals to proteins with bifunctional chelating agents (1984) (38)
- Selectivity of antibody-chelate conjugates for binding copper in the presence of competing metals (1993) (38)
- X-ray crystal structure of a macrocyclic copper chelate stable enough for use in living systems: Copper(II) dihydrogen 6-(p-nitrobenzyl)-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetate (1987) (38)
- Targeted protein footprinting: where different transcription factors bind to RNA polymerase. (1999) (38)
- Proximity mapping the surface of a membrane protein using an artificial protease: demonstration that the quinone-binding domain of subunit I is near the N-terminal region of subunit II of cytochrome bd. (1995) (37)
- Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. (1985) (37)
- A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series. (2003) (37)
- Distance between metal-binding sites in transferrin: energy transfer from bound terbium (III) to iron (III) or manganese (III). (1981) (36)
- Synthesis of novel 1,4,7-triazacyclononane-N,N',N"-triacetic acid derivatives suitable for protein labeling. (1992) (35)
- Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy. (1999) (34)
- Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins (2004) (34)
- Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma. (2000) (33)
- Photosensitization of cobalt bleomycin (1986) (33)
- The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model. (2015) (33)
- Attachment of fluorescent metal chelates to macromolecules using "bifunctional" chelating agents. (1977) (33)
- Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice. (1989) (32)
- Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. (2000) (32)
- Exchange interaction contribution to energy transfer between ions in the rapid-diffusion limit (1981) (32)
- Synthesis of a cleavable dinucleotide photoaffinity probe of ribonucleic acid polymerase: application to trinucleotide labeling of an Escherichia coli transcription complex. (1983) (31)
- Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes (2018) (31)
- Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. (1991) (31)
- Photoinduced DNA strand scission by cobalt bleomycin green complex (1989) (31)
- Physical and chemical properties of radionuclide therapy. (2000) (30)
- Study of carbonic anhydrase using perturbed angular correlations of gamma radiation. (1969) (30)
- Chelate radiochemistry: Cleavable linkers lead to altered levels of radioactivity in the liver (1988) (29)
- Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. (1981) (29)
- Critical Lym-1 binding residues on polymorphic HLA-DR molecules. (1999) (28)
- The Use of lndium-111-Labeled Leukocytes for Abscess Detection (1978) (28)
- Diffusion-enhanced energy transfer shows accessibility of ribonucleic acid polymerase inhibitor binding sites. (1981) (28)
- Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. (1998) (27)
- Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography. (1992) (26)
- Converting weak binders into infinite binders. (2004) (26)
- Helix packing in the lactose permease of Escherichia coli: distances between site-directed nitroxides and a lanthanide. (2001) (25)
- Biodistribution in tumour‐bearing mice of two 90Y‐labelled biotins using three‐step tumour targeting (1997) (25)
- Energy transfer between terbium and iron bound to transferrin: reinvestigation of the distance between metal-binding sites. (1977) (25)
- Enzymatic cleavage of peptide-linked radiolabels from immunoconjugates. (1999) (24)
- Mapping protein-protein interactions by localized oxidation: consequences of the reach of hydroxyl radical. (2009) (24)
- Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system. (2003) (24)
- Evaluation of catheter thrombogenicity in vivo with indium-labeled platelets. (1980) (23)
- Diffusion-enhanced lanthanide energy-transfer study of DNA-bound cobalt(III) bleomycins: comparisons of accessibility and electrostatic potential with DNA complexes of ethidium and acridine orange. (1985) (23)
- Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid [correction of diethylenetetraminepentaacetic acid]. (2000) (23)
- Site-Directed Photocleavage for Mapping Protein Architecture (1999) (23)
- Interaction of anions with iron-transferrin-chelate complexes. (1977) (23)
- Antibodies with infinite affinity: origins and applications. (2006) (23)
- N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates. (1990) (23)
- New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor. (1998) (22)
- Electrostatic properties of myoglobin probed by diffusion-enhanced energy transfer (1983) (22)
- Photo-induced nicking of deoxyribonucleic acid by ruthenium(II)-bleomycin in the presence of air. (1985) (22)
- The sigma subunit of RNA polymerase contacts the leading ends of transcripts 9-13 bases long on the lambda PR promoter but not on T7 A1. (1986) (22)
- Principles and methods of affinity cleavage in studying transcription. (2003) (22)
- Strategies for enhancement of radioimmunotherapy. (1991) (21)
- Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent. (1994) (20)
- Identification of a key structural feature of cobalt(III)-bleomycins: an exogenous ligand (e.g. hydroperoxide) bound to cobalt. (1983) (20)
- Photoaffinity labeling of RNA polymerase III transcription complexes by nascent RNA. (1990) (19)
- Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymatic digestion in vitro and in vivo. (1992) (19)
- The study of 111 In-labeled compounds in mice, using perturbed angular correlations of gamma radiations. (1972) (19)
- Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. (1989) (19)
- Irreversibly binding anti-metal chelate antibodies: Artificial receptors for pretargeting. (2006) (19)
- Perturbed angular correlation study of a haptenic molecule. (1972) (19)
- Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma. (2001) (19)
- Release of the sigma subunit from Escherichia coli RNA polymerase transcription complexes is dependent on the promoter sequence. (1989) (18)
- Positioning of sigma(S), the stationary phase sigma factor, in Escherichia coli RNA polymerase-promoter open complexes. (1999) (18)
- Pretargeted peptide imaging and therapy. (1999) (18)
- Effect of Molecular Shape and Flexibility on Gamma‐Ray Directional Correlations (1972) (18)
- Improved synthesis of 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N",N"-tetraacetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents. (1995) (18)
- Mapping the sigma70 subunit contact sites on Escherichia coli RNA polymerase with a sigma70-conjugated chemical protease. (1998) (18)
- Comparative oxidations of tyrosines and methionines in transferrins: human serum transferrin, human lactotransferrin, and chicken ovotransferrin. (1983) (18)
- Irreversible engineering of the multielement-binding antibody 2D12.5 and its complementary ligands. (2004) (18)
- Dimeric Association of Escherichia coli RNA Polymerase α Subunits, Studied by Cleavage of Single-Cysteine α Subunits Conjugated to Iron−(S)-1-[p-(Bromoacetamido)benzyl]ethylenediaminetetraacetate† (1998) (18)
- The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2‐(p‐Nitrobenzyl)‐1,4,7,10‐tetraazacyclododecane‐N,N′,N′′,N′′′‐tetraacetic Acid (VI) and Study of Its Yttrium(III) Complex. (1988) (17)
- Early steps in the path of nascent ribonucleic acid across the surface of ribonucleic acid polymerase, determined by photoaffinity labeling. (1981) (17)
- Mapping protein-protein interactions with a library of tethered cutting reagents: the binding site of sigma 70 on Escherichia coli RNA polymerase. (1999) (17)
- Molecular tools for targeted imaging and therapy of cancer (2003) (17)
- A convenient and flexible approach for introducing linkers on bifunctional chelating agents. (1992) (15)
- Bifunctional chelating agents for radiometal-labeled monoclonal antibodies. (1990) (15)
- Chemically modified antibodies as diagnostic imaging agents. (2010) (14)
- Electrophilic chelating agents for irreversible binding of metal chelates to engineered antibodies. (2002) (14)
- The study of biological macromolecules using perturbed angular correlations of gamma radiation. (1972) (14)
- Enhancing peptide ligand binding to vascular endothelial growth factor by covalent bond formation. (2012) (14)
- Photoaffinity labeling of Escherichia coli RNA polymerase/poly[d(A-T)] transcription complexes by nascent RNA. (1988) (13)
- Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer. (1994) (13)
- Positioning of Region 4 of the Escherichia coli RNA Polymerase ς70 Subunit by a Transcription Activator (2000) (13)
- New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation. (2011) (13)
- Rates and equilibria for probe capture by an antibody with infinite affinity. (2010) (12)
- Proteolytic DNA for mapping protein-DNA interactions. (2002) (12)
- Radiolytic protein surface mapping. (1996) (12)
- Technetium-99 m complexes of EDTA analogs: studies of the radiochemistry and biodistribution. (1981) (11)
- Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy. (1995) (11)
- Large‐Scale Synthesis of the Bifunctional Chelating Agent 2‐(p‐ Nitrobenzyl)‐1,4,7,10‐tetraazacyclododecane‐N,N′,N′′,N′′′‐tetraacetic Acid, and the Determination of Its Enantiomeric Purity by Chiral Chromatography. (1993) (10)
- Metal decomposition rates of 111In‐DPTA and EDTA conjugates of monoclonal antibodies in vivo (1986) (10)
- New approaches to delivering metal-labeled antibodies to tumors : Synthesis and characterization of new biotinyl chelate conjugates for pre-targeted diagnosis and therapy (1996) (10)
- Accessibility of the leading end of ribonucleic acid in transcription complexes. (1986) (9)
- Evaluation of cleavable (Tyr3)-octreotate derivatives for longer intracellular probe residence. (2004) (9)
- 67 Cu- versus 131 I-Labeled Lym-1 Antibody: Comparative Pharmacokinetics and Dosimetry in Patients with Non-Hodgkin’s Lymphoma 1 (1999) (8)
- Subunit contacts of the rifamycin binding site of RNA polymerase (B. subtilis). (1978) (8)
- Properties In Vivo of Chelate-Tagged Proteins and Polypeptides (1982) (8)
- Footprint of the sigma protein: a re-examination. (1991) (8)
- The chemistry of irreversible capture. (2008) (8)
- Editorial: Introduction to bioconjugate chemistry (1990) (8)
- Footprint of the sigma protein. (1989) (8)
- Effects of sigma subunit and DNA template on the accessibility of rifamycin bound to RNA polymerase. (1982) (8)
- Benzocyclobutene radical anion (1970) (8)
- Ring strain effects. IV. An electron spin resonance study of the radical anions of a series of strained naphthalene hydrocarbons (1974) (7)
- BIFUNCTIONAL CHELATING AGENTS: LINKING RADIOMETALS TO BIOLOGICAL MOLECULES (1982) (7)
- METABOLIZABLE IN‐111 CHELATE CONJUGATED ANTI‐IDIOTYPE MONOCLONAL ANTIBODY FOR RADIOIMMUNODETECTION OF LYMPHOMA IN MICE (1984) (7)
- Perspectives in bioconjugate chemistry (1993) (7)
- Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor (2014) (7)
- Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics. (2012) (6)
- Cysteinylated protein as reactive disulfide: an alternative route to affinity labeling. (2008) (6)
- Radiolabeled antitumor agents. (1976) (5)
- Pharmacokinetics of indium-111 BLEDTA in man. (1984) (5)
- Conjugation of Bifunctional Chelating Agents to Bleomycin for Use in Nuclear Medicine (1979) (5)
- PRETARGETED IMMUNOSCINTIGRAPHY WITH IN‐111, GA‐67 AND GA‐68 LABELED BIVALENT (“JANUS”) HAPTENS.: A3 (1988) (5)
- Indium-111 Labeled Cells: New Approaches and Radiation Dosimetry (1985) (5)
- Metal-Complex-Catalyzed Cleavage of Biopolymers (1995) (5)
- Diffusion-enhanced lanthanide energy transfer studies of protein prosthetic groups. (1980) (5)
- Rapid PCR construction of a gene containing Lym-1 antibody variable regions. (1993) (5)
- Biological properties of molecules labeled with metal ions using bifunctional chelates (1977) (4)
- Metallic Radionuclides for Radioimmunotherapy (2000) (4)
- Introduction to gene silencing and delivery. (2012) (4)
- Pilot therapy trial of CEA positive tumours using a three-step pretargeting approach (1998) (4)
- Radiopharmaceutical preparation of a monoclonal antibody, lym‐1, and its F(ab')2 fragment for imaging lymphoma with In‐111 (1989) (4)
- Mapping the Path of a Growing Ribonucleic Acid Molecule (1991) (4)
- Study of biological macromolecules by diffusion-enhanced lanthanide energy transfer (1989) (4)
- The Design of a Radiolabeled Monoclonal Antibody for Radioimmunodiagnosis and Radioimmunotherapy (1988) (4)
- The interaction of anions with native and phenylglyoxal-modified human serum transferrin. (1987) (4)
- Sequences of the Lym-1 antibody heavy and light chain variable regions. (1990) (4)
- Improved Synthesis of 6‐(p‐(Bromoacetamido)benzyl)‐1,4,8,11‐ tetraazacyclotetradecane‐N,N′,N′′,N′′′‐tetraacetic Acid (I) and Development of a Thin‐Layer Assay for Thiol‐Reactive Bifunctional Chelating Agents. (1995) (4)
- Metabolite production in patients with lymphoma after radiometal-labeled antibody administration. (2001) (4)
- Therapy Trials in Cancer Patients Using an Improved 3-Step Pretargeting Approach (1997) (4)
- Organization of Open Complexes at Escherichia coliPromoters (1999) (4)
- Bifunctional Chelates for Radio-Pharmaceutical Labeling (1975) (4)
- BLEDTA: TUMOR LOCALIZATION BY A BLEOMYCIN ANALOG CONTAINING A METAL-CHELATING GROUP (1980) (3)
- Artificial iron-dependent proteases. (2001) (3)
- Ring strain effects on spin densities I. Ring strain effects on spin densities in substituted naphthalenem radical anions (1968) (3)
- Antibodies with Infinite Affinity: Origins and Applications (2007) (3)
- Dimeric association of Escherichia coli RNA polymerase alpha subunits, studied by cleavage of single-cysteine alpha subunits conjugated to iron-(S)-1-[p-(bromoacetamido)benzyl]ethylenediaminetetraacetate. (1998) (2)
- Targeted instant immunity (2009) (2)
- Use of Bifunctional Chelating Agents for Radiolabeling Antibodies (1986) (2)
- LYMPHOSCINTIGRAPHY WITH IN‐111 LABELED MONOCLONAL ANTIBODIES: A4 (1983) (2)
- Bifunctional chelates for radiopharmaceutical labeling (1974) (2)
- Conjugation of antibodies with metal chelates (1989) (2)
- Peptide–Metal Interactions (2006) (2)
- PRETARGETED Y-90 THERAPY: PHARMACOKINETICS AND THERAPEUTIC RATIO IN BALB/C MICE WITH KHJJ MOUSE ADENOCARCINOMA USING MAB 2D12.5 AND Y-88 JANUS DOTA (1993) (2)
- Erratum: Effect of molecular shape and flexibility on gamma-ray directional correlations (Journal of Chemical Physics (1972) 57 (364 )) (1972) (1)
- Editorial: Whatʼs New (2008) (1)
- Editorial: What's New (2002) (1)
- An Aminobenzyldioxocyclam Nickel(II) Complex (1995) (1)
- Interaction of oxidized chicken ovotransferrin with chicken embryo red blood cells. (1985) (1)
- Pretargeting (1997) (1)
- Editorial - What's New for 1995 (1995) (1)
- Radioactive Isotopes in Clinical Medicine and Research (2009) (1)
- IMMUNOGENICITY OF (S) AND (R) ENANTIOMERS OF A MACROCYCLIC BIFUNCTIONAL CHELATING AGENT WITH IMMUNOCONJUGATES IN RABBITS (1992) (1)
- Pretargeted Immunoscintigraphy: Effectof HaptenValencyon MurineTumorUptake (1992) (1)
- EDITORIAL: What's New for 1997 (1997) (1)
- Mapping an antibody binding site by nuclear decay (1997) (1)
- Editorial: Thanks to Our Reviewers (1992) (1)
- Reagent and method for radioimaging leukocytes (1987) (1)
- EDITORIAL: No More Hardcopy Submissions (2006) (1)
- Amphiphilic spectroscopic probes utilizing metal chelates (1979) (1)
- Quantitative photoaffinity labeling of Escherichia coli RNA polymerase transcription complexes by nascent RNA (1989) (1)
- Cellular and in vivo properties of 64Cu-labeled irreversible and reversible peptide ligands against VEGF (2014) (0)
- Development of techniques for rapid analysis of 90Sr breakthrough and 90Y activity from a 90Sr-90Y generator (1986) (0)
- Peptide–Metal InteractionsBased in part on the article Peptide–Metal Interactions by Justin K. Moran & Claude F. Meares which appeared in the Encyclopedia of Inorganic Chemistry, First Edition. (2011) (0)
- Editorial: The Twentieth Year of Bioconjugate Chemistry (2009) (0)
- RECENT ADVANCES IN ANTIBODY RADIOCHEMISTRY FOR RAID AND RAIT (1994) (0)
- RECEPTOR SPECIFIC PEPTIDES: GA-68–2IT-BABE-GRGDS FOR THROMBUS IMAGING WITH PET (1994) (0)
- Corrections - Electrostatic Properties of Myoglobin Probed by Diffusion-Enhanced Energy Transfer (1984) (0)
- EDITORIAL: Bioconjugate Chemistry in 2013 (2013) (0)
- United States Patent ( 19 ) Meares et al . Patent Number : 11 ) 4 , 678 , 667 Date of Patent : ( 54 ) MACROCYCLIC BIFUNCTIONAL CHELATENGAGENTS 75 ) Inventors : (0)
- Erratum: Protein-protein interactions mapped by artificial proteases: Where σ factors bind to RNA polymerase (TiBs 25 (408-414)) (2000) (0)
- Ligand-Receptor Systems with Infinite Binding Affinity (2014) (0)
- Patent Number : 45 Date of Patent : 54 METHOD AND SYSTEM FOR ADMINISTERING THERAPEUTIC (2017) (0)
- RECENT ADVANCES IN CHEMISTRY RELATED TO ANTIBODY TARGETING (2008) (0)
- RADIOCHEMISTRY AIMD RADIOPHARMACEUTICALS lndium-111-Labeled Autologous Platelets for Location of Vascular Thrombi in Humans (2008) (0)
- X-Ray Crystal Structure of a Macrocyclic Copper Chelate Stable Enough for Use in Living Systems: Copper(II) Dihydrogen 6-(p-Nitrobenzyl)-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetate. (1988) (0)
- Chelates for Radioimmunodiagnosis and Therapy' (2006) (0)
- Identification of the optimal Cu-64 bifunctional chelator for radioimmunodetection of neuroblastoma (2009) (0)
- RING STRAIN EFFECTS PART 4, AN ELECTRON SPIN RESONANCE STUDY OF THE RADICAL ANIONS OF A SERIES OF STRAINED NAPHTHALINE HYDROCARBONS (1974) (0)
- In-111 chelate conjugates of human transferrin (HTr) and mouse monoclonal anti human transferrin receptor antibody (. cap alpha. HTrR MoAb) for tumor imaging (1984) (0)
- Cell surface expression of an engineered antibody as a PET reporter gene for in vivo PET imaging (2008) (0)
- EDITORIAL: Thanks to Our Editorial Advisory Board and Reviewers (2010) (0)
- Characterization of the ant ige nie epitope recognized by tumor selective antibody (1997) (0)
- Attachment of bifunctional chelating agents to amphiphilic molecules and antibiotics (1979) (0)
- The influence of the sigma subunit and DNA template on the accessibility of the rifamycin binding site on RNA polymerase (1982) (0)
- Physiological barriers to chelate-tagged monoclonals? (1987) (0)
- Centralized Access is Here! Featuring. (1995) (0)
- Effect of Mass of ' "In-Benzyl-EDTA Monoclonal Antibody on Hepatic Uptake and Processing in Mice1 (2006) (0)
- Label-Free Determination of Protein Binding in Aqueous Solution using Overlayer Enhanced Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (OE-ATR-FTIR) (2009) (0)
- acid (DOTA)-.Peptide-ChL6, a Novel linmunoconjugate with Catabolizable Linker, to 2-Iminothiolane-2- (p-(Bromoacetamido)benzyl)-DOTA-ChL6 in Breast Cancer Xenografts' (1998) (0)
- Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer. (1990) (0)
- Pretargeting: Improved Pharmacokinetics and Therapeutic Ratio (1997) (0)
- Editorial: What's new for 1993 (1993) (0)
- Bleomycin conjugates and method (1989) (0)
- Advances in Blood Cell Labeling: Pretargeting (1994) (0)
- Crystal Structure of Monoclonal Antibody 2D12.5 Fab Complexed with Gd-DOTA (2003) (0)
- Photosensitization of Cobalt Bleomycin. (1987) (0)
- EDITORIAL: What's New for 1998 (1998) (0)
- Monoklonala antikroppar against metallkelat (1986) (0)
- EDITORIAL: Special Section on Imaging Chemistry (2004) (0)
- Binding ofthe70protein tothecoresubunits ofEscherichia coliRNA polymerase, studied byiron-EDTAprotein footprinting (1996) (0)
- Perturbed Angular Correlation StudyofaHaptenic Molecule (rotational label/anti-Dnp/radioactive/11"In) (1972) (0)
- Pretargeted Peptide Delivery with Irreversible Antibody (2016) (0)
- Interaction of Anions with Iron l Transferrin l Chelate Complexes (2002) (0)
- Clinical Studieswith In-i 11 BLEDTA, A Tumor-ImagingConjugateof Bleomycin with a BifunctionalChelatingAgent (2006) (0)
- Conjugates of antibodies and metal chelates in cancer therapy (1995) (0)
- RADIOCHEMISTRY: THE ATTACHMENT OF METAL-CHELATING GROUPS TO PROTEINS (1979) (0)
- Erratum: Electrostatic properties of myoglobin probed by diffusion-enhanced energy transfer (Biochemistry (1983) 22, 26, (6247-6254)) (1984) (0)
- Photoaffinity labeling of a promoter dependent eukaryotic transcription complex (1986) (0)
- SELECTIVE BINDING OF METAL IONS TO MACROMOLECULES USING BIFUNCTIONAL ANALOGS OF EDTA (1975) (0)
- Therapeutic or radiodiagnostic substance. (1987) (0)
- Microscale synthesis and bio distribution studies of platinum 195m labeled cis di chloro di ammine platinum ii (1979) (0)
- Labeling cell membranes with bifunctional chelates (1981) (0)
- Pharmacokinetics of Chimeric Ui Conjugated to Indium-ill-and Yttrium.90-DOTA-Peptide in Tumor-Bearing Mice (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Claude F. Meares?
Claude F. Meares is affiliated with the following schools:
